Inactive Instrument

Other languages OUTLOOK THERAPEUTICS, INC. Nasdaq

Equities

US68235M1053

Other languages

Unlock all the news: Be the first to know and act before the market!

Abbott Laboratories : , Boeing, Paramount... les valeurs à suivre aujourd'hui à Wall Street	08/07
Outlook Therapeutics: le Lytenava autorisé au Royaume-Uni contre la DMLA	08/07
Outlook Therapeutics Granted EU Marketing Authorization for Lytenava to Treat Wet AMD	28/05
Outlook Therapeutics, Inc. Receives European Commission Marketing Authorization for LYTENAVA? (bvacizumab grapa) for the Treatment of Wet AMD	28/05
Outlook Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	16/05
Outlook Therapeutics Submits Marketing Application for Wet Age-related Macular Degeneration Therapy in UK	13/05
Outlook Therapeutics, Inc. Announces UK Submission of Marketing Authorization Application for ONS-5010 as a Treatment for Wet AMD	13/05
Outlook Therapeutics Shares Rise After BTIG Upgrade	28/03
Outlook Therapeutics Reports Secondary Share Offering	26/03
Sector Update: Health Care Stocks Ease Late Afternoon	23/03
Sector Update: Health Care Stocks Ease Friday Afternoon	22/03
Sector Update: Health Care Stocks Steady Pre-Bell Friday	22/03
Outlook Therapeutics Gets EMA Panel Positive Opinion for Wet AMD Treatment -- Shares Rise Pre-Bell	22/03
Outlook Therapeutics Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD	22/03
Madrigal Pharmaceuticals : Super Micro Computer, Madrigal, Tencent... les valeurs à suivre aujourd'hui à Wall Street -	19/03
Outlook Therapeutics lève 60 millions de dollars pour l'approbation de son bevacizumab	19/03
Outlook Therapeutics Shares Climb Following Upgrade by Chardan	16/02
Outlook Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	15/02
Outlook Therapeutics Doses First Patient in Eye Disease Study	31/01
Outlook Therapeutics, Inc. Doses First Subject in Norse Eight	31/01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages OUTLOOK THERAPEUTICS, INC. Nasdaq

Equities

US68235M1053

Other languages

Filters